Nine manufacturers, compared on the factors that actually differ. Use this to orient yourself, then read the individual brand profile before drawing conclusions, a table cannot capture why a system suits a particular case.
| Brand | Origin | Connection | Surface | Materials | Metal-free option | Price tier | Evidence base |
|---|---|---|---|---|---|---|---|
| Straumann | Switzerland | TorcFit conical; tissue & bone level | SLActive / SLA | Roxolid (Ti-Zr alloy) | No | Premium | Very large, much of it independent |
| Nobel Biocare | Sweden / Switzerland | Four families: external hex, tri-channel, conical, trioval | TiUnite / TiUltra | Titanium; zirconia (NobelPearl) | Yes, NobelPearl | Premium | Very large; longest follow-up in the field |
| BioHorizons | United States (Henry Schein) | Internal hex; conical (Tapered Pro Conical) | RBT + Laser-Lok collar | Titanium | No | Mid to upper-mid | Substantial, heavily manufacturer-funded |
| Camlog | Germany / Switz. (Henry Schein) | CAMLOG; CONELOG conical; Hexalobe (ceramic) | Promote | Titanium; zirconia (CERALOG) | Yes, CERALOG, incl. two-piece | Upper-mid | Moderate; ceramic line newer |
| Neodent | Brazil (Straumann Group) | Grand Morse conical | Acqua / NeoPoros | Titanium; zirconia (Zi) | Yes, Neodent Zi | Value to mid | Smaller; group-backed |
| MegaGen | South Korea | Internal, system-dependent | Xpeed | Titanium | No | Mid to value | Smaller and more recent |
| Hiossen | South Korea (Osstem) | 11° Morse taper, platform-switched | SA (sandblasted, acid-etched) | Titanium | No | Mid to value | Smaller; largely manufacturer-associated |
| bredent | Germany | System-dependent across SKY family | System-dependent | Titanium; zirconia (whiteSKY); BioHPP prosthetics | Yes, whiteSKY | Mid | Substantial but largely laboratory work |
| Implant Direct | United States (Envista) | Internal hex (Legacy); conical (InterActive) | SBM | Titanium | No | Value | Thinner; leans on testimonial literature |
How to read this table
Tier reflects what a manufacturer charges, which is driven by research spending, sales structure and brand position as much as by manufacturing. Every system listed here is made by an established manufacturer to medical-device standards. A value-tier implant placed well by an experienced surgeon will outperform a premium implant placed poorly, every time.
This column reflects how much published research exists that was not produced or funded by the manufacturer, and how long patients have been followed. A large evidence base reduces uncertainty about long-term behaviour. It does not guarantee your outcome, and a smaller evidence base is not proof of a problem, it means less is known.
Of every column here, connection geometry has the most durable practical consequence. It determines which components can ever be fitted to your implant. Whatever system you receive, get the connection and platform recorded in writing.
Who actually owns these brands
The nine systems on this page look like nine independent competitors. They are not. Consolidation in implant dentistry has been extensive, and four corporate parents control most of what a Canadian patient will be offered.
| Parent | Brands on this site | Positioning |
|---|---|---|
| Straumann Group | StraumannNeodent | Premium and value tiers under one owner |
| Envista | Nobel BiocareImplant Direct | Premium and value tiers under one owner |
| Henry Schein Global Oral Reconstruction Group | BioHorizonsCamlog | Joined 2016; marketed together |
| Osstem | Hiossen | Hiossen is Osstem's North American division |
| Independent | MegaGenbredent | Still independently owned |
Two things follow from it. First, when a practice offers you a "premium option" and a "budget option"those two systems may well come from the same corporation, Straumann and Neodent, or Nobel Biocare and Implant Direct. That does not make the price difference illegitimate, but it does mean the choice is less independent than it appears. Second, corporate backing genuinely matters for the question that should concern you most: whether components for your implant will still be available in twenty or thirty years. A brand owned by a large parent is a safer long-term bet than a small independent one, whatever the badge on the box says.
What actually determines whether your implant succeeds
It is worth stating plainly, because comparison tables invite the opposite conclusion: the brand is not the main variable. Across the published literature, the factors most strongly associated with implant failure are smoking, uncontrolled diabetes, untreated gum disease, poor oral hygiene, inadequate bone volume, and inexperience or error on the part of the operator. Modern implants from established manufacturers have converged substantially in design, and their survival rates in ordinary cases are broadly similar.
This does not make system choice irrelevant. It matters for parts availability, for restorative flexibility, and in difficult cases where a specific design genuinely helps. But if you are weighing two quotes and the only difference is the brand, the more useful questions are about the surgeon's experience, how your case was planned, and what happens if something goes wrong.